This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1996 May 18;347(9012):1346-7.

doi: 10.1016/s0140-6736(96)91004-1.

Are we ready for factor V Leiden screening?

Affiliations

PMID: 8637335
DOI: 10.1016/s0140-6736(96)91004-1

Comment

Are we ready for factor V Leiden screening?

B Dahlbäck. Lancet. 1996.

. 1996 May 18;347(9012):1346-7.

doi: 10.1016/s0140-6736(96)91004-1.

Author

Affiliation

¹ Department of Clinical Chemistry, University of Lund, University Hospital, Malmö, Sweden.

PMID: 8637335
DOI: 10.1016/s0140-6736(96)91004-1

No abstract available

PubMed Disclaimer

Comment on

Resistance to activated protein C in an unselected population of patients with pulmonary embolism.
Desmarais S, de Moerloose P, Reber G, Minazio P, Perrier A, Bounameaux H. Desmarais S, et al. Lancet. 1996 May 18;347(9012):1374-5. doi: 10.1016/s0140-6736(96)91013-2. Lancet. 1996. PMID: 8637344 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.